http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103764843-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103764843-B |
| titleOfInvention | For the method and composition for the risk for determining heart failure or heart failure |
| abstract | The present invention is based partially on the discovery of miR groups, and the level of the miR is increased or decreased in the circulation that chronic cardiac shrinks HF patient.Therefore, in the serum that stable chronic cardiac shrinks HF patient, large-scale miR groups are screened, and result is compared with the control group that age, sex and race match. |
| priorityDate | 2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 673.